P497: CLINICAL OUTCOMES OF NPM1-MUTATED ACUTE MYELOID LEUKEMIA (AML) PATIENTS WITH MEASURABLE RESIDUAL DISEASE (MRD) RELAPSE AFTER ACHIEVEMENT OF A FIRST MRD-NEGATIVE REMISSION

• Madlen Jentzsch,
• Lara Bischof,
• Jule Ussmann,
• Dominic Brauer,
• Donata Backhaus,
• Tung Pham Thanh,
• Georg-Nikolaus Franke,
• Vladan Vucinic,
• Uwe Platzbecker,
• Sebastian Schwind

Affiliations

Madlen Jentzsch

1 University Hospital Leipzig, Medical Clinic I - Hematology and Cellular Therapy, Leipzig, Germany

Lara Bischof

1 University Hospital Leipzig, Medical Clinic I - Hematology and Cellular Therapy, Leipzig, Germany

Jule Ussmann

1 University Hospital Leipzig, Medical Clinic I - Hematology and Cellular Therapy, Leipzig, Germany

Dominic Brauer

1 University Hospital Leipzig, Medical Clinic I - Hematology and Cellular Therapy, Leipzig, Germany

Donata Backhaus

1 University Hospital Leipzig, Medical Clinic I - Hematology and Cellular Therapy, Leipzig, Germany

Tung Pham Thanh

1 University Hospital Leipzig, Medical Clinic I - Hematology and Cellular Therapy, Leipzig, Germany

Georg-Nikolaus Franke

1 University Hospital Leipzig, Medical Clinic I - Hematology and Cellular Therapy, Leipzig, Germany

Vladan Vucinic

1 University Hospital Leipzig, Medical Clinic I - Hematology and Cellular Therapy, Leipzig, Germany

Uwe Platzbecker

1 University Hospital Leipzig, Medical Clinic I - Hematology and Cellular Therapy, Leipzig, Germany

Sebastian Schwind

1 University Hospital Leipzig, Medical Clinic I - Hematology and Cellular Therapy, Leipzig, Germany